Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

331

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Vasomotor RhinitisSeasonal Allergic Rhinitis

Interventions

DRUG

Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg

Phenylephrine HCl ER tablets 30 mg taken every 12 hours, twice daily, for 3 days.

DRUG

Phenylephrine Hydrochloride (HCl) Immediate Release (IR) tablets, 10 mg

Phenylephrine HCl IR tablets 10 mg taken every four hours (no more than 6 times daily) for 3 days.